|
|
| |
| Scientific Committee |
 |
|
| HCV PROGRAM DIRECTOR |
 |
Stefan Zeuzem, Germany Klinikum der J.W. Goethe-Universitat, Med. Klinik 1
 |
|
HBV PROGRAM DIRECTOR |
 |
Fabien Zoulim, France INSERM U1052, Lyon University, Hepatology Department, Hospices Civils de Lyon
 |
| SCIENTIFIC COMMITTEE |
 |
David Back, UK Department of Molecular and Clinical Pharmacology, University of Liverpool |
 |
Thomas Berg, Germany Head of the Division of Hepatology, Department of Internal Medicine, Clinic of Gastroenterology and Rheumatology, University Hospital Leipzig
 |
 |
Raffaele Bruno, Italy Department of Infectious Diseases, Hepatology Outpatients Unit, University of Pavia Fondazione IRCCS, Policlinico San Matteo, Pavia
 |
 |
Maria Buti, Spain Hospital Valle Hebron, Barcelona
 |
 |
Bonaventura Clotet, Spain HIV Unit and irsicaixa Foundation, University Hospital “Germans Trias i Pujol”, Badalona, Catalonia
 |
 |
Douglas T. Dieterich, USA Professor of Medicine, Mount Sinai School of Medicine, New York
 |
 |
Geoffrey Dusheiko, UK UCL Centre for Hepatology, University College London Medical School, and Royal Free Hospital, London |
 |
Rafael Esteban, Spain Vall d’Hebron University Hospital |
 |
Michael P. Manns, Germany Hannover Medical School, Department of Gastroenterology, Hepatology and Endocrinology
 |
 |
Stefan Mauss, Germany Center for HIV and Hepatogastroenterology, Duesseldorf
 |
 |
Jean Michel Pawlotsky, France Department of Virology, Henri Mondor Hospital, University of Paris
 |
 |
Carlo Perno, Italy Tor Vergata University Hospital, Rome |
 |
Marion Peters, USA Chief of Hepatology Research, Division of Gastroenterology, University of California, San Francisco
 |
 |
Jörg Petersen, Germany Liver Unit, IFI Institute for Interdisciplinary Medicine, Asklepios Klinik St. Georg, Hamburg
 |
 |
Massimo Puoti, Italy Department of Infectious Diseases. AO Ospedale Niguarda Ca’ Granda, Milan
 |
 |
Vicente Soriano, Spain Hospital Carlos III, Madrid
 |
 |
Mark R. Thursz, UK Professor of Hepatology, Imperial College, London
 |
 |
Hans L. Tillmann, USA Duke Clinical Research Institute
 |
 |
Heiner Wedemeyer, Germany Hannover Medical School
 |
|
|
|
|